Stock data
Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. (RVMD) reported revenue of US$0.00M and net income of -US$1.13B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$1.18B | -US$1.13B | — |
| 2024 | US$0.00M | — | -US$689.52M | -US$600.09M | — |
| 2023 | US$11.58M | — | -US$487.19M | -US$436.37M | — |
| 2022 | US$35.38M | — | -US$258.28M | -US$248.71M | — |
| 2021 | US$29.39M | — | -US$188.01M | -US$187.09M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$644.37M | — |
| 2026-03-31 | — | -US$453.82M | — |
| 2025-12-31 | — | -US$364.89M | — |
| 2025-09-30 | — | -US$305.21M | — |
| 2025-06-30 | — | -US$247.79M | — |
| 2025-03-31 | — | -US$213.42M | — |
| 2024-12-31 | US$0.00M | -US$194.57M | — |
| 2024-09-30 | US$0.00M | -US$156.29M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.